The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Continuous Blood Glucose Monitoring-Global Market Insights and Sales Trends 2024

Continuous Blood Glucose Monitoring-Global Market Insights and Sales Trends 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1851998

No of Pages : 105

Synopsis
Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
The global Continuous Blood Glucose Monitoring market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Continuous Blood Glucose Monitoring in various end use industries. The expanding demands from the Hospitals, Clinics and Home Care,, are propelling Continuous Blood Glucose Monitoring market. Self-Monitoring Blood Glucose Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Continuous Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Continuous Blood Glucose Monitoring, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Continuous Blood Glucose Monitoring market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Continuous Blood Glucose Monitoring market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Continuous Blood Glucose Monitoring sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Continuous Blood Glucose Monitoring covered in this report include Roche, Lifescan, Medtronic, Bayer AG, Abbott, Terumo, Dexcom, Echo Therapeutics and B. Braun Melsungen, etc.
The global Continuous Blood Glucose Monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Lifescan
Medtronic
Bayer AG
Abbott
Terumo
Dexcom
Echo Therapeutics
B. Braun Melsungen
Arkray
Cellnovo Group
Nemaura
Tandem Diabetes Care
Global Continuous Blood Glucose Monitoring market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Continuous Blood Glucose Monitoring market, Segment by Type:
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Global Continuous Blood Glucose Monitoring market, by Application
Hospitals
Clinics
Home Care
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Continuous Blood Glucose Monitoring manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Continuous Blood Glucose Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Continuous Blood Glucose Monitoring Market Overview
1.1 Continuous Blood Glucose Monitoring Product Overview
1.2 Continuous Blood Glucose Monitoring Market Segment by Type
1.2.1 Self-Monitoring Blood Glucose Systems
1.2.2 Continuous Glucose Monitoring Systems
1.3 Global Continuous Blood Glucose Monitoring Market Size by Type
1.3.1 Global Continuous Blood Glucose Monitoring Market Size Overview by Type (2018-2029)
1.3.2 Global Continuous Blood Glucose Monitoring Historic Market Size Review by Type (2018-2023)
1.3.3 Global Continuous Blood Glucose Monitoring Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Continuous Blood Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.2 Europe Continuous Blood Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Continuous Blood Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Continuous Blood Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Continuous Blood Glucose Monitoring Sales Breakdown by Type (2018-2023)
2 Global Continuous Blood Glucose Monitoring Market Competition by Company
2.1 Global Top Players by Continuous Blood Glucose Monitoring Sales (2018-2023)
2.2 Global Top Players by Continuous Blood Glucose Monitoring Revenue (2018-2023)
2.3 Global Top Players by Continuous Blood Glucose Monitoring Price (2018-2023)
2.4 Global Top Manufacturers Continuous Blood Glucose Monitoring Manufacturing Base Distribution, Sales Area, Product Type
2.5 Continuous Blood Glucose Monitoring Market Competitive Situation and Trends
2.5.1 Continuous Blood Glucose Monitoring Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Continuous Blood Glucose Monitoring Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring as of 2022)
2.7 Date of Key Manufacturers Enter into Continuous Blood Glucose Monitoring Market
2.8 Key Manufacturers Continuous Blood Glucose Monitoring Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Continuous Blood Glucose Monitoring Status and Outlook by Region
3.1 Global Continuous Blood Glucose Monitoring Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Continuous Blood Glucose Monitoring Historic Market Size by Region
3.2.1 Global Continuous Blood Glucose Monitoring Sales in Volume by Region (2018-2023)
3.2.2 Global Continuous Blood Glucose Monitoring Sales in Value by Region (2018-2023)
3.2.3 Global Continuous Blood Glucose Monitoring Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Continuous Blood Glucose Monitoring Forecasted Market Size by Region
3.3.1 Global Continuous Blood Glucose Monitoring Sales in Volume by Region (2024-2029)
3.3.2 Global Continuous Blood Glucose Monitoring Sales in Value by Region (2024-2029)
3.3.3 Global Continuous Blood Glucose Monitoring Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Continuous Blood Glucose Monitoring by Application
4.1 Continuous Blood Glucose Monitoring Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home Care
4.2 Global Continuous Blood Glucose Monitoring Market Size by Application
4.2.1 Global Continuous Blood Glucose Monitoring Market Size Overview by Application (2018-2029)
4.2.2 Global Continuous Blood Glucose Monitoring Historic Market Size Review by Application (2018-2023)
4.2.3 Global Continuous Blood Glucose Monitoring Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Continuous Blood Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.2 Europe Continuous Blood Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Continuous Blood Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Continuous Blood Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Continuous Blood Glucose Monitoring Sales Breakdown by Application (2018-2023)
5 North America Continuous Blood Glucose Monitoring by Country
5.1 North America Continuous Blood Glucose Monitoring Historic Market Size by Country
5.1.1 North America Continuous Blood Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Continuous Blood Glucose Monitoring Sales in Volume by Country (2018-2023)
5.1.3 North America Continuous Blood Glucose Monitoring Sales in Value by Country (2018-2023)
5.2 North America Continuous Blood Glucose Monitoring Forecasted Market Size by Country
5.2.1 North America Continuous Blood Glucose Monitoring Sales in Volume by Country (2024-2029)
5.2.2 North America Continuous Blood Glucose Monitoring Sales in Value by Country (2024-2029)
6 Europe Continuous Blood Glucose Monitoring by Country
6.1 Europe Continuous Blood Glucose Monitoring Historic Market Size by Country
6.1.1 Europe Continuous Blood Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Continuous Blood Glucose Monitoring Sales in Volume by Country (2018-2023)
6.1.3 Europe Continuous Blood Glucose Monitoring Sales in Value by Country (2018-2023)
6.2 Europe Continuous Blood Glucose Monitoring Forecasted Market Size by Country
6.2.1 Europe Continuous Blood Glucose Monitoring Sales in Volume by Country (2024-2029)
6.2.2 Europe Continuous Blood Glucose Monitoring Sales in Value by Country (2024-2029)
7 Asia-Pacific Continuous Blood Glucose Monitoring by Region
7.1 Asia-Pacific Continuous Blood Glucose Monitoring Historic Market Size by Region
7.1.1 Asia-Pacific Continuous Blood Glucose Monitoring Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Continuous Blood Glucose Monitoring Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Continuous Blood Glucose Monitoring Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Continuous Blood Glucose Monitoring Forecasted Market Size by Region
7.2.1 Asia-Pacific Continuous Blood Glucose Monitoring Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Continuous Blood Glucose Monitoring Sales in Value by Region (2024-2029)
8 Latin America Continuous Blood Glucose Monitoring by Country
8.1 Latin America Continuous Blood Glucose Monitoring Historic Market Size by Country
8.1.1 Latin America Continuous Blood Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Continuous Blood Glucose Monitoring Sales in Volume by Country (2018-2023)
8.1.3 Latin America Continuous Blood Glucose Monitoring Sales in Value by Country (2018-2023)
8.2 Latin America Continuous Blood Glucose Monitoring Forecasted Market Size by Country
8.2.1 Latin America Continuous Blood Glucose Monitoring Sales in Volume by Country (2024-2029)
8.2.2 Latin America Continuous Blood Glucose Monitoring Sales in Value by Country (2024-2029)
9 Middle East and Africa Continuous Blood Glucose Monitoring by Country
9.1 Middle East and Africa Continuous Blood Glucose Monitoring Historic Market Size by Country
9.1.1 Middle East and Africa Continuous Blood Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Continuous Blood Glucose Monitoring Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Continuous Blood Glucose Monitoring Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Continuous Blood Glucose Monitoring Forecasted Market Size by Country
9.2.1 Middle East and Africa Continuous Blood Glucose Monitoring Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Continuous Blood Glucose Monitoring Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Continuous Blood Glucose Monitoring Products Offered
10.1.5 Roche Recent Development
10.2 Lifescan
10.2.1 Lifescan Company Information
10.2.2 Lifescan Introduction and Business Overview
10.2.3 Lifescan Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lifescan Continuous Blood Glucose Monitoring Products Offered
10.2.5 Lifescan Recent Development
10.3 Medtronic
10.3.1 Medtronic Company Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medtronic Continuous Blood Glucose Monitoring Products Offered
10.3.5 Medtronic Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Information
10.4.2 Bayer AG Introduction and Business Overview
10.4.3 Bayer AG Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer AG Continuous Blood Glucose Monitoring Products Offered
10.4.5 Bayer AG Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Continuous Blood Glucose Monitoring Products Offered
10.5.5 Abbott Recent Development
10.6 Terumo
10.6.1 Terumo Company Information
10.6.2 Terumo Introduction and Business Overview
10.6.3 Terumo Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Continuous Blood Glucose Monitoring Products Offered
10.6.5 Terumo Recent Development
10.7 Dexcom
10.7.1 Dexcom Company Information
10.7.2 Dexcom Introduction and Business Overview
10.7.3 Dexcom Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Dexcom Continuous Blood Glucose Monitoring Products Offered
10.7.5 Dexcom Recent Development
10.8 Echo Therapeutics
10.8.1 Echo Therapeutics Company Information
10.8.2 Echo Therapeutics Introduction and Business Overview
10.8.3 Echo Therapeutics Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Echo Therapeutics Continuous Blood Glucose Monitoring Products Offered
10.8.5 Echo Therapeutics Recent Development
10.9 B. Braun Melsungen
10.9.1 B. Braun Melsungen Company Information
10.9.2 B. Braun Melsungen Introduction and Business Overview
10.9.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.9.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Products Offered
10.9.5 B. Braun Melsungen Recent Development
10.10 Arkray
10.10.1 Arkray Company Information
10.10.2 Arkray Introduction and Business Overview
10.10.3 Arkray Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Arkray Continuous Blood Glucose Monitoring Products Offered
10.10.5 Arkray Recent Development
10.11 Cellnovo Group
10.11.1 Cellnovo Group Company Information
10.11.2 Cellnovo Group Introduction and Business Overview
10.11.3 Cellnovo Group Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cellnovo Group Continuous Blood Glucose Monitoring Products Offered
10.11.5 Cellnovo Group Recent Development
10.12 Nemaura
10.12.1 Nemaura Company Information
10.12.2 Nemaura Introduction and Business Overview
10.12.3 Nemaura Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Nemaura Continuous Blood Glucose Monitoring Products Offered
10.12.5 Nemaura Recent Development
10.13 Tandem Diabetes Care
10.13.1 Tandem Diabetes Care Company Information
10.13.2 Tandem Diabetes Care Introduction and Business Overview
10.13.3 Tandem Diabetes Care Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Tandem Diabetes Care Continuous Blood Glucose Monitoring Products Offered
10.13.5 Tandem Diabetes Care Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Continuous Blood Glucose Monitoring Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Continuous Blood Glucose Monitoring Industrial Chain Analysis
11.4 Continuous Blood Glucose Monitoring Market Dynamics
11.4.1 Continuous Blood Glucose Monitoring Industry Trends
11.4.2 Continuous Blood Glucose Monitoring Market Drivers
11.4.3 Continuous Blood Glucose Monitoring Market Challenges
11.4.4 Continuous Blood Glucose Monitoring Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Continuous Blood Glucose Monitoring Distributors
12.3 Continuous Blood Glucose Monitoring Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’